Trials / Completed
CompletedNCT02621307
Effect of Salba & Flax on Postprandial Glycemia and Subjective Satiety
The Effect of Salba (Salvia Hispanica L) Versus Flax on Postprandial Blood Glucose Response and Subjective Appetite in Healthy Individuals
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Unity Health Toronto · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether drinks containing Salvia hispanica L (Salba) or Flax lower postprandial blood glucose levels and improve appetite in healthy individuals.
Detailed description
Dietary fibre has been implicated in improving many risk factors associated with Type 2 Diabetes and Cardiovascular Disease (CVD). However, on average, Norther Americans consume less than half of the recommended amount set by health agencies. It has been proposed that the health benefits of dietary fibre may be attritbuted to rheological characteristics such as viscosity. Salvia hispanica L (Salba) and Flax are nutritionally similar. The primary objective of this research trial is to study the effects of Salba and Flax on postprandial glycemia and appetite in healthy individuals.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Salba | |
| DIETARY_SUPPLEMENT | Flax | |
| DIETARY_SUPPLEMENT | Control |
Timeline
- Start date
- 2010-07-01
- Primary completion
- 2011-07-01
- Completion
- 2011-07-01
- First posted
- 2015-12-03
- Last updated
- 2015-12-03
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02621307. Inclusion in this directory is not an endorsement.